PTC Therapeutics Inc.

10/04/2019 | Press release | Distributed by Public on 10/04/2019 06:01

PTC Therapeutics Announces New Real-World Analysis Demonstrating Translarna™ (ataluren) Slows Disease Progression in Patients with Duchenne Muscular Dystrophy